APO RESEARCH · REPORT
Alinia (nitazoxanide)
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
Product & engineering
Understand the product.
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
Selected research
Industry Research
Alinia (nitazoxanide) Industry Research Report 2026
Market perspective
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.
Report Scope
Read the full market overview
This report quantifies the global Alinia (nitazoxanide) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Alinia (nitazoxanide) Market by Company
Romark Laboratories
Chugai Pharmaceutical
Lupin
Alinia (nitazoxanide) Segment by Type
Tablets
Oral Suspension
Alinia (nitazoxanide) Segment by Application
Retail Pharmacy
Hospital
Others
Alinia (nitazoxanide) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alinia (nitazoxanide) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alinia (nitazoxanide) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alinia (nitazoxanide).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Alinia (nitazoxanide) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Alinia (nitazoxanide) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Alinia (nitazoxanide) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Oral Suspension
Applications
- Retail Pharmacy
- Hospital
- Others
Companies covered
- Romark Laboratories
- Chugai Pharmaceutical
- Lupin
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Alinia (nitazoxanide) Market Size (2021-2032)
- 2.2.2 Global Alinia (nitazoxanide) Sales (2021-2032)
- 2.2.3 Global Alinia (nitazoxanide) Market Average Price (2021-2032)
- 2.3 Alinia (nitazoxanide) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Oral Suspension
- 2.4 Alinia (nitazoxanide) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacy
- 2.4.3 Hospital
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Alinia (nitazoxanide) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Alinia (nitazoxanide) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Alinia (nitazoxanide) Revenue of Manufacturers (2021-2026)
- 3.4 Global Alinia (nitazoxanide) Average Price by Manufacturers (2021-2026)
- 3.5 Global Alinia (nitazoxanide) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Alinia (nitazoxanide), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Alinia (nitazoxanide), Product Type & Application
- 3.8 Global Manufacturers of Alinia (nitazoxanide), Established Date
- 3.9 Global Alinia (nitazoxanide) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Romark Laboratories
- 4.1.1 Romark Laboratories Company Information
- 4.1.2 Romark Laboratories Business Overview
- 4.1.3 Romark Laboratories Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Romark Laboratories Alinia (nitazoxanide) Product Portfolio
- 4.1.5 Romark Laboratories Recent Developments
- 4.2 Chugai Pharmaceutical
- 4.2.1 Chugai Pharmaceutical Company Information
- 4.2.2 Chugai Pharmaceutical Business Overview
- 4.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio
- 4.2.5 Chugai Pharmaceutical Recent Developments
- 4.3 Lupin
- 4.3.1 Lupin Company Information
- 4.3.2 Lupin Business Overview
- 4.3.3 Lupin Alinia (nitazoxanide) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lupin Alinia (nitazoxanide) Product Portfolio
- 4.3.5 Lupin Recent Developments
5 Global Alinia (nitazoxanide) Market Scenario by Region
- 5.1 Global Alinia (nitazoxanide) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Alinia (nitazoxanide) Sales by Region: 2021-2032
- 5.2.1 Global Alinia (nitazoxanide) Sales by Region: 2021-2026
- 5.2.2 Global Alinia (nitazoxanide) Sales by Region: 2027-2032
- 5.3 Global Alinia (nitazoxanide) Revenue by Region: 2021-2032
- 5.3.1 Global Alinia (nitazoxanide) Revenue by Region: 2021-2026
- 5.3.2 Global Alinia (nitazoxanide) Revenue by Region: 2027-2032
- 5.4 North America Alinia (nitazoxanide) Market Facts & Figures by Country
- 5.4.1 North America Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Alinia (nitazoxanide) Sales by Country (2021-2032)
- 5.4.3 North America Alinia (nitazoxanide) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Alinia (nitazoxanide) Market Facts & Figures by Country
- 5.5.1 Europe Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Alinia (nitazoxanide) Sales by Country (2021-2032)
- 5.5.3 Europe Alinia (nitazoxanide) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Alinia (nitazoxanide) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Alinia (nitazoxanide) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Alinia (nitazoxanide) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Alinia (nitazoxanide) Market Facts & Figures by Country
- 5.7.1 South America Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Alinia (nitazoxanide) Sales by Country (2021-2032)
- 5.7.3 South America Alinia (nitazoxanide) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Alinia (nitazoxanide) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Alinia (nitazoxanide) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Alinia (nitazoxanide) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Alinia (nitazoxanide) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Alinia (nitazoxanide) Sales by Type (2021-2032)
- 6.1.1 Global Alinia (nitazoxanide) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Alinia (nitazoxanide) Sales Market Share by Type (2021-2032)
- 6.2 Global Alinia (nitazoxanide) Revenue by Type (2021-2032)
- 6.2.1 Global Alinia (nitazoxanide) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Alinia (nitazoxanide) Revenue Market Share by Type (2021-2032)
- 6.3 Global Alinia (nitazoxanide) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Alinia (nitazoxanide) Sales by Application (2021-2032)
- 7.1.1 Global Alinia (nitazoxanide) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Alinia (nitazoxanide) Sales Market Share by Application (2021-2032)
- 7.2 Global Alinia (nitazoxanide) Revenue by Application (2021-2032)
- 7.2.1 Global Alinia (nitazoxanide) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Alinia (nitazoxanide) Revenue Market Share by Application (2021-2032)
- 7.3 Global Alinia (nitazoxanide) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Alinia (nitazoxanide) Value Chain Analysis
- 8.1.1 Alinia (nitazoxanide) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Alinia (nitazoxanide) Production Mode & Process
- 8.2 Alinia (nitazoxanide) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Alinia (nitazoxanide) Distributors
- 8.2.3 Alinia (nitazoxanide) Customers
9 Global Alinia (nitazoxanide) Analyzing Market Dynamics
- 9.1 Alinia (nitazoxanide) Industry Trends
- 9.2 Alinia (nitazoxanide) Industry Drivers
- 9.3 Alinia (nitazoxanide) Industry Opportunities and Challenges
- 9.4 Alinia (nitazoxanide) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst